![Jason Keyes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Keyes
Finansdirektör/CFO på
BLOSSOMHILL THERAPEUTICS, INC.
Förmögenhet: 12 810 $ per 2026-08-31
Profil
Jason A. Keyes is Independent Director at Actuate Therapeutics, Inc. since 2024.
Mr. Keyes is Chief Financial Officer & Executive Vice President at Blossomhill Therapeutics, Inc. starting in 2025.
Former roles include Chief Financial Officer at Equillium, Inc. from 2018 to 2025, Independent Director at Sesen Bio, Inc. from 2020 to 2023, Chief Financial Officer & Executive Vice President at Orexigen Therapeutics, Inc. from 2016 to 2018, Senior Director-Finance at Amylin Pharmaceuticals, Inc. from 2007 to 2013, and Head-Finance & Strategy at Amgen, Inc. Education includes undergraduate and graduate degrees from Stanford University and an MBA from UCLA Anderson School of Management.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-10 | 700 ( 0 % ) | 12 810 $ | 2026-08-31 | |
| 2026-05-21 | 0 ( -.--% ) | - $ | 2026-08-31 |
Aktiva positioner av Jason Keyes
| Företag | Position | Start |
|---|---|---|
| ACTUATE THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2024-08-12 |
| BLOSSOMHILL THERAPEUTICS, INC. | Finansdirektör/CFO | 2025-05-01 |
Tidigare kända positioner av Jason Keyes
| Företag | Position | Slut |
|---|---|---|
| EQUILLIUM, INC. | Finansdirektör/CFO | 2025-04-25 |
| CARISMA THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2023-03-07 |
| OREXIGEN THERAPEUTICS, INC. | Finansdirektör/CFO | 2018-02-23 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Finansdirektör/CFO | 2013-01-01 |
| AMGEN INC. | Företagsledare/Principal | - |
Jason Keyess utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
60
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel therapeutics which target cancers and neurodegenerative diseases | Health Technology |
Equillium, Inc.
 Equillium, Inc. BiotechnologyHealth Technology Engages in the development of products for severe immune-inflammatory disorders | Health Technology |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
